Video Teaser: Learnings from the last decade of clinical evidence on HMOs
Breastfeeding is the best way to feed an infant. New science highlights the unique diversity of human milk oligosaccharides (HMOs) for the mother-infant dyad. HMOs now with clinical evidence of benefits, ranging from establishing the developing microbiome, immune system to promising benefits in neurocognition. Rapidly growing body of evidence that specific and clinically studied HMOs when added to infant formula, have shown functional benefits. 2’FL and LNnT are among the most studied HMOs with clinical evidence to support immunity and the developing microbiome.
This is a video teaser with key points of the presentation of Ryan Carvalho’s during the NNI online Satellite Symposia as scheduled for WCPGHAN 2020. Click in the link below if you want to see Ryan Carvalho’s full talk: